Fermenta Biotech Limited SHARE PRICE [LIVE]

BSE: INE225B01021   NSE: -   SECTOR: -

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
N/A
Change:
BSE
196.40
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Fermenta Biotech Limited

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

News

Frequently Asked Questions

What is the Share price of Fermenta Biotech Limited ()?

Fermenta Biotech Limited () share price as of August 9, 2022, on BSE is Rs 196.40 (BSE).

Can I buy Fermenta Biotech Limited () shares?

Yes, You can buy Fermenta Biotech Limited () shares by opening a Demat account with Angel One.

How do I buy Fermenta Biotech Limited () from Angel One?

Fermenta Biotech Limited () share can be brought through the following modes:
  1. Direct investment: You can buy Fermenta Biotech Limited () shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Fermenta Biotech Limited () shares.

About

Today's live share price for Fermenta Biotech Limited is NSE: N/A, BSE: ₹ 196.40 with a current market capitalization of .

Promoted by a technocrat, D V K Raju, Duphar-Interfran (DIL) was incorporated in May '51 as International Franchises Pvt Ltd. In the initial years, the company manufactured and sold toothpaste, anti-septic lotion and pharmaceutical specialities on a loan-licence basis. It entered into collaborations with Philips-Duphar, Amsterdam (Solvay Duphar), and the Crookes Laboratories, London. These collaborators participated in the equity capital of the company to the extent of 25% each. The company changed its name to Crookes Interfran on 19 Apr.'63. In 1964, it entered into a collaboration with Solvay Duphar to manufacture vitamin D3. To associate fully with its research-oriented collaborators, in May '71, it changed its name to Duphar-Interfran. In 1976, it entered into another collaboration with Solvay Duphar to manufacture isoxypurine hydrochloride -- a vasodilator. In 1976, in compliance with the FERA, the foreign collaborators reduced thier stake to 38.86%. DIL came out with a rights issue in May '95 to augment long-term resources and working capital requirements. The company also sold its popular analgesic brand Crocin to Smithkline Beecham Pharmaceuticals. It also sold another OTC brand, Lacto-Calamine lotion to Nicholas Piramal to concentrate on the core business of ethical drugs. As per the Scheme of Arrangement, the pharma business of the company has been transferred to a new company called Duphar Pharma India. The Company has made investments in unutilised premises at Thane to create a commercial complex with modern facilities so that substantial portion of it can be let out to earn income. The successful entry of Annual Contract with Solvay Pharmaceuticals B V of Netherlands will definitely establish as a reliable contract research organization for Duphar Interfran Ltd. As mutual consent with Solvay Pharmaceuticals,Netherlands,the company has been permitted to continue with the name DUPHAR for a limited time. It has also been decided to change the name to DIL Limited from Duphar-Interfran Ltd. With the prior approval from Board the company has acquired 990,000 equity shares of Rs.10 each in Fermenta Biotech Ltd there by increase its holding to 83.71% comprising 16,57,500 equity shares. Subsequent to this FBL will henceforth be a subsidiary of Duphar Interfran Ltd.

Read more